All news - CHEManager

News

Johnson Matthey to Sell its Medical Device Components Business

25.03.2024 -

UK’s Johnson Matthey (JM) has signed a definitive agreement to sell 100% of its Medical Device Components (MDC) business to Montagu Private Equity for $700 million (£550...

News

Schott Pharma to Build New US Prefillable Syringe Manufacturing Facility

25.03.2024 -

In a move to triple its production of glass and polymer syringes for the US market by 2030, Germany’s Schott Pharma announced plans to build its first US facility to...

News

AstraZeneca to Buy Fusion Pharmaceuticals for Up to $2.4 Billion

25.03.2024 -

AstraZeneca has agreed to acquire Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).

News

Merck Invests in New Production Site for its Life Science Business

22.03.2024 -

Merck is pouring over €300 million into a new Bioprocessing Production Centre in Daejeon, South Korea. This marks the largest investment by Merck's Life Science sector in...

News

Afyren Neoxy Gets €3.4 Million in After-Biochem Project

22.03.2024 -

Greentech firm Afyren Neoxy, a subsidiary of Afyren, received a €3.4 million payment this week for achieving key milestones with its bio-based low-carbon products.

News

Evonik and Vland Biotech Begin Joint Venture

21.03.2024 -

Evonik Vland Biotech, a new joint venture between Evonik China and Shandong Vland Biotech, began operations on January 1, 2024. The venture aims to expand the market...

News

Lonza Buys Biologics Plant From Roche for $1.2 Billion

21.03.2024 -

Lonza has signed an agreement to acquire Genentech's biologics manufacturing site in Vacaville, California (USA) from Roche. The Swiss pharmaceutical company announced...

Chemistry & Life Sciences

Securing Supply Chains and Strengthening Partnerships 

20.03.2024 -

Interview with Edgardo Hernandez, President Manufacturing, Lilly